MTOR and hepatocellular carcinoma: Our results showed that HCC cell lines exhibited an increased lenvatinib IC50 value after overexpressing circRNA‐mTOR, whereas interfering with circRNA‐mTOR expression led to a decreased lenvatinib IC50 value in HCC cell lines (Figure4A; Figure S2A, Supporting Information).